|Articles|June 13, 2022
Syner-G Biopharma Group Appoints Ron Kraus as CEO
Kraus brings more than 25 years of experience leading life sciences companies, including global responsibility for customer strategy, sales, operations, and various support functions.
Advertisement
Syner-G BioPharma Group announced that Ron Kraus has joined the company as Chief Executive Officer (CEO). Kraus has more than 25 years of experience leading life sciences companies, including global responsibility for customer strategy, sales, operations, and various support functions.
Prior to joining Syner-G, Kraus was Chief Operating Officer at Cytel. He succeeds Syner-G’s founder, Prabu Nambiar, PhD, MBA, RAC, as CEO.
Read more about Kraus' appointment
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: IntraGel & UroGen Sign Collaboration & Investment Agreements, Lupin & Tenpoint Form Commercialization Collaboration
2
Pharmaceutical Executive Daily: Amplitude Therapeutics Partners with Eli Lilly
3
Roundup: Amplitude Therapeutics, Chai Discovery Enter Collaborations with Eli Lilly, Bristol Myers Squibb
4
When Drug Pricing Becomes Trade Policy
5